David Wu

2.1k total citations · 1 hit paper
12 papers, 1.8k citations indexed

About

David Wu is a scholar working on Molecular Biology, Genetics and Neurology. According to data from OpenAlex, David Wu has authored 12 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Molecular Biology, 4 papers in Genetics and 2 papers in Neurology. Recurrent topics in David Wu's work include RNA modifications and cancer (2 papers), Growth Hormone and Insulin-like Growth Factors (2 papers) and interferon and immune responses (1 paper). David Wu is often cited by papers focused on RNA modifications and cancer (2 papers), Growth Hormone and Insulin-like Growth Factors (2 papers) and interferon and immune responses (1 paper). David Wu collaborates with scholars based in United States and Switzerland. David Wu's co-authors include Tsutomu Nobori, Kenji Takabayashi, Kaoru Miura, Augusto F. Lois, Dennis A. Carson, José-Luis Castrillo, Michael Karin, Lars E. Theill, Sharon Dana and Jeannine S. Strobl and has published in prestigious journals such as Nature, Cell and Analytical Biochemistry.

In The Last Decade

David Wu

10 papers receiving 1.7k citations

Hit Papers

Deletions of the cyclin-dependent kinase-4 inhibitor gene... 1994 2026 2004 2015 1994 400 800 1.2k

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
David Wu United States 4 1.1k 866 350 249 179 12 1.8k
Scott M. Kahn United States 16 994 0.9× 1.0k 1.2× 272 0.8× 181 0.7× 191 1.1× 24 1.9k
Augusto F. Lois United States 10 1.1k 1.0× 966 1.1× 343 1.0× 179 0.7× 42 0.2× 14 1.9k
Regina Raz United States 15 1.0k 1.0× 1.0k 1.2× 280 0.8× 190 0.8× 124 0.7× 20 2.0k
Yoshinori Naoe Japan 27 1.3k 1.2× 820 0.9× 259 0.7× 360 1.4× 35 0.2× 60 3.0k
Masakuni Serizawa Japan 26 694 0.7× 663 0.8× 493 1.4× 338 1.4× 110 0.6× 86 1.9k
M. Kay Washington United States 20 738 0.7× 556 0.6× 284 0.8× 224 0.9× 65 0.4× 34 1.6k
Hiroaki Mita Japan 23 1.5k 1.4× 502 0.6× 337 1.0× 146 0.6× 26 0.1× 52 2.0k
Riku Katainen Finland 18 618 0.6× 280 0.3× 287 0.8× 126 0.5× 79 0.4× 33 1.6k
John G. Emery United States 16 1.4k 1.3× 611 0.7× 433 1.2× 142 0.6× 75 0.4× 20 2.0k

Countries citing papers authored by David Wu

Since Specialization
Citations

This map shows the geographic impact of David Wu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David Wu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David Wu more than expected).

Fields of papers citing papers by David Wu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David Wu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David Wu. The network helps show where David Wu may publish in the future.

Co-authorship network of co-authors of David Wu

This figure shows the co-authorship network connecting the top 25 collaborators of David Wu. A scholar is included among the top collaborators of David Wu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David Wu. David Wu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

12 of 12 papers shown
1.
Manhas, Amit, Yu Liu, Chikage Noishiki, et al.. (2025). Multiscale profiling of tyrosine kinase inhibitor cardiotoxicity reveals mechanosensitive ion channel PIEZO1 as cardioprotective. Science Translational Medicine. 17(829). eadv9403–eadv9403.
2.
Wu, David, Amit Manhas, Chikage Noishiki, et al.. (2025). Generation of induced pluripotent stem cell line from a patient with long COVID. Stem Cell Research. 83. 103652–103652.
3.
Manhas, Amit, Chikage Noishiki, David Wu, et al.. (2024). Generation of two iPSC lines from vascular Ehlers-Danlos Syndrome (vEDS) patients carrying a missense mutation in COL3A1 gene. Stem Cell Research. 79. 103485–103485. 2 indexed citations
4.
Thomas, Dilip, Chikage Noishiki, Sadhana Gaddam, et al.. (2024). CCL2-mediated endothelial injury drives cardiac dysfunction in long COVID. Nature Cardiovascular Research. 3(10). 1249–1265. 10 indexed citations
5.
Manhas, Amit, et al.. (2024). Generation of two iPSC lines from dilated cardiomyopathy patients with pathogenic variants in the SCN5A gene. Stem Cell Research. 80. 103498–103498. 1 indexed citations
7.
Manhas, Amit, Chikage Noishiki, David Wu, et al.. (2023). Generation of induced pluripotent stem cell line from a patient suffering from arterial calcification due to deficiency of CD73 (ACDC). Stem Cell Research. 75. 103285–103285. 2 indexed citations
8.
Nobori, Tsutomu, Kaoru Miura, David Wu, et al.. (1994). Deletions of the cyclin-dependent kinase-4 inhibitor gene in multiple human cancers. Nature. 368(6473). 753–756. 1474 indexed citations breakdown →
9.
Nobori, Tsutomu, et al.. (1992). A polymerase chain reaction-based method for isolation of gene-specific sequences from the interferon-α gene cluster. Analytical Biochemistry. 205(1). 42–46. 2 indexed citations
10.
Wu, David, Linda Reynolds, Dennis A. Carson, & Tsutomu Nobori. (1991). Molecular Genetic Analysis of Chromosome 9p in Methylthioadenosine Phosphorylase Deficient Glioma Cell Lines. Advances in experimental medicine and biology. 309B. 207–211. 1 indexed citations
11.
Theill, Lars E., José-Luis Castrillo, David Wu, & Michael Karin. (1989). Dissection of functional domains of the pituitary-specific transcription factor GHF-1. Nature. 342(6252). 945–948. 220 indexed citations
12.
McCormick, Alison A., David Wu, José-Luis Castrillo, et al.. (1988). Extinction of growth hormone expression in somatic cell hybrids involves repression of the specific trans-activator GHF-1. Cell. 55(2). 379–389. 80 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026